Balentine LLC boosted its position in Agilent Technologies, Inc. (NYSE:A) by 2.9% in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,794 shares of the medical research company’s stock after buying an additional 50 shares during the period. Balentine LLC’s holdings in Agilent Technologies were worth $106,000 at the end of the most recent quarter.
Other institutional investors have also recently modified their holdings of the company. Jennison Associates LLC bought a new stake in Agilent Technologies in the 2nd quarter valued at about $212,000. Commerce Bank bought a new stake in Agilent Technologies in the 2nd quarter valued at about $1,242,000. Skandinaviska Enskilda Banken AB publ increased its position in Agilent Technologies by 5.7% in the 1st quarter. Skandinaviska Enskilda Banken AB publ now owns 64,834 shares of the medical research company’s stock valued at $3,428,000 after buying an additional 3,489 shares in the last quarter. Delta Lloyd Asset Management N.V. bought a new stake in Agilent Technologies in the 2nd quarter valued at about $2,026,000. Finally, Prudential Financial Inc. increased its position in Agilent Technologies by 2.5% in the 2nd quarter. Prudential Financial Inc. now owns 457,503 shares of the medical research company’s stock valued at $27,134,000 after buying an additional 11,020 shares in the last quarter.
In other Agilent Technologies news, CEO Michael R. Mcmullen sold 16,492 shares of Agilent Technologies stock in a transaction that occurred on Thursday, September 14th. The shares were sold at an average price of $65.33, for a total value of $1,077,422.36. Following the completion of the sale, the chief executive officer now owns 211,872 shares of the company’s stock, valued at approximately $13,841,597.76. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Didier Hirsch sold 15,555 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $66.00, for a total transaction of $1,026,630.00. Following the completion of the sale, the chief financial officer now directly owns 178,557 shares of the company’s stock, valued at approximately $11,784,762. The disclosure for this sale can be found here. In the last ninety days, insiders sold 170,720 shares of company stock valued at $10,795,039.
A number of analysts recently commented on A shares. Deutsche Bank AG reaffirmed a “buy” rating and issued a $66.00 target price on shares of Agilent Technologies in a research report on Thursday, June 22nd. BidaskClub lowered Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Tuesday, June 13th. Jefferies Group LLC reissued a “buy” rating and set a $66.00 price objective on shares of Agilent Technologies in a report on Wednesday, August 9th. Barclays PLC reissued a “buy” rating and set a $67.00 price objective on shares of Agilent Technologies in a report on Wednesday, July 19th. Finally, Janney Montgomery Scott boosted their price objective on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, August 16th. Four analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $65.12.
Agilent Technologies, Inc. (NYSE:A) traded down 0.18% during trading on Tuesday, hitting $66.44. The stock had a trading volume of 181,705 shares. The stock’s 50-day moving average price is $64.78 and its 200-day moving average price is $59.61. The company has a market capitalization of $21.38 billion, a P/E ratio of 34.27 and a beta of 1.30. Agilent Technologies, Inc. has a 1-year low of $42.92 and a 1-year high of $66.77.
Agilent Technologies (NYSE:A) last posted its earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping analysts’ consensus estimates of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The business had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter in the previous year, the firm posted $0.49 EPS. The firm’s revenue was up 6.7% on a year-over-year basis. Analysts expect that Agilent Technologies, Inc. will post $2.32 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, October 25th. Shareholders of record on Tuesday, October 3rd will be given a $0.132 dividend. This represents a $0.53 dividend on an annualized basis and a yield of 0.79%. The ex-dividend date of this dividend is Monday, October 2nd. Agilent Technologies’s dividend payout ratio (DPR) is presently 27.32%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.